GLTO
Galecto, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.58
−3.36%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -1.04x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 2.26x
Liquidity & coverage
- Current ratio
- 22.48x
- Quick ratio
- 22.48x
- Cash ratio
- 22.38x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $511.6M
Cash & dividend
- FCF / debt
- -18.56x
- Cash flow / debt
- -18.56x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026